Ronan Desmond

2.3k total citations · 1 hit paper
30 papers, 1.4k citations indexed

About

Ronan Desmond is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Ronan Desmond has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 7 papers in Genetics and 6 papers in Oncology. Recurrent topics in Ronan Desmond's work include Hematopoietic Stem Cell Transplantation (13 papers), Acute Myeloid Leukemia Research (10 papers) and Platelet Disorders and Treatments (9 papers). Ronan Desmond is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Acute Myeloid Leukemia Research (10 papers) and Platelet Disorders and Treatments (9 papers). Ronan Desmond collaborates with scholars based in United States, Ireland and Brazil. Ronan Desmond's co-authors include Cynthia E. Dunbar, Neal S. Young, Katherine R. Calvo, Colin O. Wu, Phillip Scheinberg, Bogdan Dumitriu, Danielle M. Townsley, Matthew J. Olnes, Xingmin Feng and Ankur R. Parikh and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ronan Desmond

28 papers receiving 1.4k citations

Hit Papers

Eltrombopag Added to Standard Immunosuppression for Aplas... 2017 2026 2020 2023 2017 100 200 300

Peers

Ronan Desmond
Robert B. Geller United States
H Demuynck Belgium
J Gmür Switzerland
MS Cairo United States
Tania Jain United States
Ronan Desmond
Citations per year, relative to Ronan Desmond Ronan Desmond (= 1×) peers Henrique Bittencourt

Countries citing papers authored by Ronan Desmond

Since Specialization
Citations

This map shows the geographic impact of Ronan Desmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronan Desmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronan Desmond more than expected).

Fields of papers citing papers by Ronan Desmond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronan Desmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronan Desmond. The network helps show where Ronan Desmond may publish in the future.

Co-authorship network of co-authors of Ronan Desmond

This figure shows the co-authorship network connecting the top 25 collaborators of Ronan Desmond. A scholar is included among the top collaborators of Ronan Desmond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronan Desmond. Ronan Desmond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Young, David J., Xing Fan, Emma M. Groarke, et al.. (2022). Long‐term eltrombopag for bone marrow failure depletes iron. American Journal of Hematology. 97(6). 791–801. 8 indexed citations
2.
Doty, Raymond T., Xing Fan, David J. Young, et al.. (2022). Studies of a mosaic patient with DBA and chimeric mice reveal erythroid cell–extrinsic contributions to erythropoiesis. Blood. 139(23). 3439–3449. 10 indexed citations
3.
McDonald, Laura, et al.. (2021). Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive Disorder. Clinical Lymphoma Myeloma & Leukemia. 21(10). 694–700. 2 indexed citations
4.
Swan, Dawn, Helen Enright, Ronan Desmond, et al.. (2021). Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices. SHILAP Revista de lepidopterología. 5. 100086–100086. 5 indexed citations
5.
Fan, Xing, Ronan Desmond, Thomas Winkler, et al.. (2020). Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias. Blood Advances. 4(8). 1700–1710. 32 indexed citations
6.
Byrne, Catherine J., Jason A. Roberts, Brett McWhinney, et al.. (2017). Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy. Clinical Microbiology and Infection. 23(9). 674.e7–674.e13. 33 indexed citations
7.
Townsley, Danielle M., Phillip Scheinberg, Thomas Winkler, et al.. (2017). Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. New England Journal of Medicine. 376(16). 1540–1550. 337 indexed citations breakdown →
8.
Zhao, Xin, Xingmin Feng, Zhijie Wu, et al.. (2017). Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia. Experimental Hematology. 58. 39–43. 11 indexed citations
9.
Byrne, Catherine J., Brett McWhinney, Jérôme Fennell, et al.. (2017). Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy. Journal of Antimicrobial Chemotherapy. 73(4). 995–1003. 44 indexed citations
10.
Winkler, Thomas, James N. Cooper, Danielle M. Townsley, et al.. (2017). Eltrombopag for Refractory Severe Aplastic Anemia: Dosing Regimens, Long-Term Follow-up, Clonal Evolution and Somatic Mutation Profiling. Blood. 130(Suppl_1). 777–777. 10 indexed citations
11.
Groarke, Emma M., et al.. (2016). The Role of Marrow Fibrosis in the Prognosis and Treatment of Myelodysplastic Syndromes: a Single Center Retrospective Study. Blood. 128(22). 5524–5524. 1 indexed citations
12.
Winkler, Thomas, Danielle Townsley, Ronan Desmond, et al.. (2016). Successful Treatment of a Diamond-Blackfan Anemia (DBA) Patient with Eltrombopag. Blood. 128(22). 2682–2682. 3 indexed citations
13.
Desmond, Ronan, Barbara Weinstein, Aparna Parikh, et al.. (2015). 56 ELTROMBOPAG FOR LOW TO INTERMEDIATE-2 RISK MYELODYSPLASTIC SYNDROME. Leukemia Research. 39. S26–S27. 3 indexed citations
14.
Ahmed, Saim, et al.. (2015). Increased incidence of symptomatic postural hypotension in multiple myeloma patients treated with subcutaneous bortezomib. Clinical Lymphoma Myeloma & Leukemia. 15. e165–e165. 1 indexed citations
15.
Desmond, Ronan, Danielle M. Townsley, Cynthia E. Dunbar, & Neal S. Young. (2014). Eltrombopag in Aplastic Anemia. Seminars in Hematology. 52(1). 31–37. 22 indexed citations
16.
Townsley, Danielle M., Ronan Desmond, Cynthia E. Dunbar, & Neal S. Young. (2013). Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes. International Journal of Hematology. 98(1). 48–55. 22 indexed citations
17.
Olnes, Matthew J., Phillip Scheinberg, Katherine R. Calvo, et al.. (2012). Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia. New England Journal of Medicine. 367(1). 11–19. 345 indexed citations
18.
Larochelle, André, Jennifer M. Gillette, Ronan Desmond, et al.. (2012). Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain. Blood. 119(8). 1848–1855. 41 indexed citations
19.
Olnes, Matthew J., Phillip Scheinberg, Katherine R. Calvo, et al.. (2011). Eltrombopag Can Stimulate Trilineage Hematopoiesis with Transfusion Independence in Patients with Refractory Severe Aplastic Anemia: Results From a Phase II Trial. Blood. 118(21). 54–54. 3 indexed citations
20.
Desmond, Ronan, et al.. (2009). Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL. American Journal of Hematology. 85(8). 607–607. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026